Dis cov ered in 1965, bone mor pho ge netic pro teins (BMPs) are a group of sev eral cyto kines belong ing to the trans form ing growth fac tor-b (TGF-b) 1 super fam ily. These pro teins have strong induc ing activ ity in bone and car ti lage for ma tion, and also have impor tant roles dur ing embry onic pat tern ing and early skel e tal devel op ment [1] . Dur ing the last decades, BMPs have been used as pow er ful os teo in duc tive com po nents in sev eral late-stage tis sue engi neering prod ucts for bone graft ing [2] . Since 2002, BMP-2 and BMP-7 received approval for spe cific clin i cal uses [3] .
Despite being exten sively inves ti gated, to date, most research has been focused only in a few BMPs, par tic u larly in BMP-2 and BMP-7, whilst little is known about the phys i o log i cal roles and the bio med i cal rel e vance for the remain ing BMPs. Both, BMP-4 and BMP-9 have been shown clearly bone-induc ing roles, as shown by their abil ity to induce oste o genic dif fer en ti a tion in C2C12 cell line [4] and ortho topic ossi fi ca tion in mice [5] . BMP-4 is also impli cated in diverse roles dur ing embry onic devel op ment, and as a dif fer enti a tion fac tor to he mat o po et ic and nerve cells [6] [7] [8] . BMP-14 (or growth and dif fer en ti a tion fac tor-5) induces mainly ten don and car ti lage for ma tion [9, 10] and has been also stud ied in heal ing of peri odon tal lig a ment [11] . BMP-11 and BMP-10 have not been iden ti fied for any bone-induc ing potential. BMP-10 has expres sion restricted solely to the heart tis sue and is essen tial to car diac morpho gen e sis [12, 13] , while BMP-11 (or growth and dif fer en ti a tion fac tor-11) has roles in the estab lish ment of axial pat tern ing [14] . In former reports, human BMP-4 and BMP-14 have been expressed in E. coli and reported to induce alka line phos pha tase marker in murine cells but these were not tested in human cells [15, 16] . In addi tion, the expres sion of human BMP-9, -10 and -11 in E. coli is not yet reported. In this work, we described the pro duc tion, purifi ca tion and bio ac tiv ity of recombinant human BMP-4, -9, -10, -11 and -14 by a novel method that was pre vi ously reported for the over ex pres sion of human BMP-2 [17] . The dif fer ent BMPs were ana lyzed by their abil ity to induce the mRNA expres sion of sev eral mark ers of bone dif fer en ti a tion in C2C12 cells and in human adult Expression, purification and osteogenic bioactivity of recombinant human BMP-4, -9, -10, -11 and -14 stem cells from adi pose tis sue. Our results sug gest a prom is ing and straight for ward way for the pro duc tion of dif fer ent BMPs, all capable of induc ing cell dif fer en ti a tion in the afore men tioned mod els.
Mate ri als and meth ods

Clon ing and expres sion of rhBMP-4, -9, -10, -11 and -14
The sequences cod ing the mature (bio ac tive) domains of human BMP-4, BMP-9, BMP-10, BMP-11/GDF-11 and BMP-14/GDF-5 were obtained from dif fer ent bac te rial clones (San ger Insti tute, UK), which con tained the full genes encod ing the human BMPs: clone ref er ence RP11-808F04 for BMP-4, RP11-463P17 for BMP-9, RP11-88N13 for BMP-10, RP11-55N12 for BMP-11, and RP11-173P06 for BMP-14. Accord ing to the data from the Uni ProtKB/Swiss-Prot data base (http://www.exp asy.org) and from the Human Genome Pro ject (http://www.en sem bl.org/homo_sapi ens), the sequences cod ing for the bio ac tive domains of these BMPs, are located in one sole exon, thus allow ing direct PCR clon ing of these BMPs from the above men tioned clones, as was pre vi ously described [17] .
DNA cod ing for the mature/bio ac tive pro tein domains was ampli fied by PCR using the prim ers indi cated in Table 1 . PCR-products were cloned in a pET-25b vec tor (Nova gen, USA) via the two restric tion sites, Bam HI and XhoI, that were used to trans form E. coli BL21(DE3) strain (Invit ro gen, UK). The restric tion sites for these enzymes were spe cific.
DNA clon ing and manip u la tion were per formed accord ing to stan dard pro to cols [18] . The integ rity of the cloned PCR products was ver i fied by DNA sequenc ing [19] using a ABI PRISM310 Genetic Ana lyzer. Trans formed E. coli BL21(DE3) strain with pET25b/rhBMP were inoc u lated in 50 ml Luria-Ber tan i (LB) medium with 50 lg ampi cil lin/ml and incu bated at 37 °C, until an OD 600 of 0.8 was obtained. To induce recombinant pro tein expres sion IPTG 1 mM was then added to the cul ture media, and the tem per a ture low ered to 25 °C dur ing 24 h. Bio mass was col lected by cen tri fuga tion (4000g, 20 min, 4 °C), washed once with PBS and stored at ¡20 °C.
Puri fi ca tion of rhBMPs
Fro zen bac te ria were resus pended in lysis buffer (20 mM sodium phos phate buffer, 0.5 M NaCl, 1 mg/ml lyso zyme), with a pro te ase inhib i tors (Com plete Mini EDTA-free, Roche). Bac te ria cells were ultr aso ni cat ed 6 times for 30 s with inter vals of 5 min on ice and super na tant and pellet frac tions col lected by cen tri fuga tion (4000g, 30 min, 4 °C). The pellet was then incu bated overnight in sol u bi li za tion buffer (phos phate saline buffer, 30 mM imid az ole, 0.7 M l-argi nine, pH 10.0) at 18 °C with gen tle stir ring and the super na tant con tain ing sol u ble rhBMP col lected after cen tri fu ga tion (4000g, 20 min, 4 °C). The pH of super na tant was adjusted to 7.5 with 0.5 M HCl and applied to a pre-equil i brated Hi sTrap chro ma tog ra phy col umn (Amersham). Briefly, the col umn was equil i brated with five col umn vol umes of sodium phos phate buffer con tain ing 30 mM imid az ole, washed exten sively with 100-120 ml of sodium phos phate buffer con tain ing 60 mM imid az ole and the sam ple eluted in 20 ml of phos phate buffer sup ple mented with 400 mM imid az ole. A flow rate of 5 ml/min was kept dur ing the whole pro ce dure by the use of a peri stal tic pump. Puri fied pro tein was desalted with the use of a Hi Trap desalt ing col umn (Amersham) and freeze-dried. BMPs were resus pended in sterile phos phate buffer saline, prior to bio ac tiv ity tests. Pro tein concen tra tion was mea sured by Brad ford method [20] using bovine serum albu min stan dards of known con cen tra tion.
Pro tein purity was esti mated using SDS-PAGE image anal y sis (Gel Pro Ana lyzer 4.0, Media Cyber net ics).
Western-blot detec tion of rhBMPs
Pro tein sam ples were mixed with SDS-PAGE load ing buffer and heated at 95 °C for 5 min. Sam ples were sep a rated by using handcast 10-12% reduced SDS-PAGE gels and coomassie blue-R was employed for visu al i za tion and stain ing of gels. Sam ples were then elec tro-trans ferred (wet Western-blot trans fer) to a nitro cel lu lose mem brane at 100 V for 60 min. The mem brane was blocked with 2% (w/v) BSA in PBS-T buffer (PBS, 0.05% Tween 20) and incu bated with per ox i dase con ju gated anti-His anti body (Sigma) diluted 1:2000. Image detec tion was per formed with Chem i Doc XRS and Quan tity One soft ware (Bio Rad).
Bio ac tiv ity tests
C2C12 cells were seeded at 2.5 £ 10 4 cells/ml per well in a 24-well plate, attached in Dul becco's mod i fied Eagle's medium (DMEM) with 1% (v/v) fetal bovine serum, 100 U/ml pen i cil lin and 100 lg/ml strepto my cin, at 37 °C with 5% CO 2 in a humid i fied envi ron ment. Cells were incu bated for 5 days with BMP-4, -9, -10, -11 and -14, puri fied by the method described above (500 ng/ml) and a con trol with no cyto kine. MTS cell via bil ity assay was per formed in C2C12 cells after 3 days of cul ture [21] . Primary cul tures of human adult stem cells iso lated from adi pose tis sue [22] were cul tured under sim i lar condi tions and incu bated with BMP-4, -9 and -14 (500 ng/ml) for 3 days of cell cul ture. For RT-PCR, the mRNA of cells was extracted with TriZol Reagent (Invit ro gen, USA) from trip li cate 24-well assays fol lowing the pro ce dure pro vide by the sup plier. Sam ples were quan ti fied using a Nano Drop ND-1000 Spec tro pho tom e ter (Nano Drop Tech nolo gies, USA) and cDNA syn the sis per formed with iScript cDNA synthe sis Kit (Bio Rad, USA). PCR was per formed with spe cific prim ers for oste o genic mark ers. Aga rose gels were visu al ized using Eagle Eye imag ing sys tem (Strat a gene) and gene expres sion was ana lyzed with Gel-Pro Ana lyzer (Media Cyber net ics), using poly mer ase II expression as a house keep ing marker.
Sta tis ti cal anal y sis
Exper i ments were per formed at least in trip li cate and expressed as means ± stan dard devi a tions. Stu dent's t test was used for statis ti cal anal y sis using a two-tailed paired test and ana lyzed by a paired anal y sis of var i ance. Sta tis ti cal sig nifi cance was defined as p < 0.05 for a 95% con fi dence.
Results
Clon ing, expres sion and puri fi ca tion of rhBMPs
The PCR orig i nated sin gle prod ucts for the cod ing regions of human BMP-4, -9, -10, -11 and -14 (data not shown). DNA sequenc ing Table 1 Oli go nu cleo tide prim ers for clon ing of human BMP-4, -9, -10, -11 and -14. revealed a total cor re spon dence to the encoded nucle o tides and corre spond ing amino acids. Esch e richia coli BL21(DE3) strain trans formants were then cul ti vated and col lected as described in Mate rial and meth ods sec tion. After cell lysis, rhBMPs were found mainly in the pellet (frac tion cor re spond ing to cell debris) (data not shown). Sol u ble pro tein was recov ered using phos phate buffer con tain ing 0.7 M l-argi nine, pH 10.0, as indi cated in Mate ri als and meth ods. After puri fi ca tion by affin ity chro ma tog ra phy, the rhBMPs were vis i ble as mono mer, dimer and poly mer, with Western-blot, using a anti body against the six-his ti dine tag (Fig. 1) . Esti mat ing from coomassie bluestained SDS-PAGE, the BMPs were pure up to 95% (Table 2) .
Cyto tox ic ity of rhBMPs
Bio as says were per formed in murine myo blast C2C12 cell line, by the admin is tra tion of puri fied rhBMP-2. The dif fer ent pro teins did not show cyto tox ic ity in C2C12 cells after three days of cell cul ture at 50 and 500 ng/ml (Fig. 2) . MTS is a via bil ity/pro lif er a tion test and an inverse rela tion ship of tox ic ity to cells can be assumed. BMP-4 (50 ng/ml), BMP-9 (50 ng/ml) and BMP-10 (500 ng/ml) signifi cantly stim u lated cell pro lif er a tion by approx i mately 10-25% (p < 0.05).
Expres sion of oste o genic mark ers induced by rhBMPs
Semi-quan ti ta tive RT-PCR revealed an increase in expres sion of sev eral early osteo blast dif fer en ti a tion mark ers in C2C12 cell line after five days of cell cul ture with the dif fer ent BMPs (Fig. 3) . The increased mRNA lev els were mean val ues of inde pen dent assays, and nor mal ized against the expres sion of poly mer ase II. Expression of early osteo chon dral tran scrip tion fac tor runx2/cbfa1 was induced by 2-to 3-fold with BMP-4 and BMP-11, 4-fold with BMP-10 and BMP-14, and 6-fold with BMP-9 (p < 0.05 in all cases). Expres sion of smad-1 and smad-5, two sig nal ing mol e cules for BMPs, were also induced but in a lower extent. The expres sion of smad-5 with induced 2-fold with BMP-4 and BMP-9 (p < 0.05). Expres sion of smad-1 was induced with BMP-9 (2-fold, p < 0.05). With BMP-10, BMP-11 and BMP-14, there was no sig nifi cant increase in the expres sion of smad-1 or -5. Os ter ix, a tran scrip tion fac tor down stream of runx2/cbfa-1 and a marker of com mit ment to osteo blas tic line age, was induced both with BMP-4 (2-fold) and BMP-9 (2-fold, p < 0.05) and its expres sion main tained with the other BMPs. Os ter ix expres sion was slightly decreased by BMP-11 (not sta tis ti cally sig nifi cant). The expres sion of tran scrip tion factor dlx5 was nearly the same with all BMPs, with a slight increase with BMP-4 (1.5-fold) which is not sig nifi cant. Alka line phos phatase (ALP), bone sialo pro tein and oste o pon tin, three mark ers of bone for ma tion, were induced with some of these BMPs. ALP was induced with BMP-4, BMP-9 (2-fold, p < 0.05) and BMP-10 and -14 (1.5-fold), and reduced by half (0.5-fold) with BMP-11 (p < 0.05). Bone sialo pro tein expres sion was up-reg u lated with BMP-14 (3-fold) and with BMP-4 (5-fold, p < 0.05). Oste o pon tin expres sion was up-reg u lated mainly with BMP-9, BMP-14 and less with BMP-4 and BMP-10 (p < 0.05), com pared with basal expres sion in the control and with BMP-11. Oste o cal cin, a marker spe cific of late-stages of bone min er al i za tion, was not detected in any assay. The observa tions on cell mor phol ogy cor re lated well with the induc tion of the sev eral oste o genic mark ers (Fig. 4) . BMP-9, and to a less degree BMP-4 and BMP-14, induced an osteo blast-like mor phol ogy.
In the primary cul tures of fat-derived human stem cells, BMP-4, BMP-9 and BMP-14 were also able to induce an increase in the expres sion of the dif fer ent early mark ers of oste o genic dif fer en ti ation (Fig. 5) . BMP-4 induced the high est lev els of oste o genic markers, par tic u larly runx2 (7-fold, p < 0.05), bone sialo pro tein (7-fold, p < 0.05) and oste o pon tin (8-fold, p < 0.05). BMP-9 induced runx2 (2-fold) and alka line phos pha tase (2-fold), while BMP-14 induced the expres sion of alka line phos pha tase (5-fold, p < 0.05) and bone sialo pro tein (3-fold, p < 0.05). Bac te ria trans formed with blank vector (e.g. no BMP) did not induce any expres sion of oste o genic genes (data not shown).
Dis cus sion
In this work we report a straight for ward meth od ol ogy for the expres sion of recombinant human BMP-4, BMP-9, BMP-10, BMP-11/GDF-11 and BMP-14/GDF-5 in E. coli, that showed bio ac tiv ity in both C2C12 cell line and human adult stem cells.
Although the con cept of over express ing BMPs in E. coli is not novel, we have shown, for the first time, the over ex pres sion of func tional BMP-9, -10 and -11 using E. coli and char ac ter ized the bio ac tiv ity of BMP-4, BMP-14 and BMP-9 using primary cul tures of human adult stem cells, which has not been shown before. Using a sin gle-step method, which was pre vi ously reported for the solu bi li za tion of rhBMP-2 [17] , the recov ery with 0.7 M l-argi nine buffer resulted in mono mer, dimer and poly mer, in a sim i lar way to former reports [23, 24] , with up to 50 mg puri fied BMPs per liter of cul ture broth. Fig. 1 . Western-blot of puri fied rhBMP-4, -9, -10, -11 and -14 and a neg a tive con trol (respec tively, 1-6) using an anti 6-His tag anti body. The BMPs are vis i ble in monomer, dimer and poly mer.
Table 2
Puri fi ca tion of recombinant human BMP-4, BMP-9, BMP-10, BMP-11 (GDF-11) and BMP-14 (GDF-5).
Steps
Crude lysate a l-Argi nine sol u bi li za tion Ni-NTA chro ma tog ra phy Smad-1 and Smad-5 were induced mostly for BMP-4, -9 and -14, Os ter ix for BMP-4 and -9, Runx2 was induced for all BMPs but higher for BMP-9. Bone sialo pro tein was induced mostly for BMP-4 and -11; ALP was induced 1.5-to 2-fold for all BMPs except BMP-11; oste o pon tin was induced mainly for BMP-9, BMP-10 and BMP-14. All tested BMPs have shown evi dence of bio ac tiv ity in C2C12 cells. C2C12 cell line is a well-known model for study ing the osteo genic dif fer en ti a tion induced by BMPs as has been reported by sev eral inves ti ga tors [17, 24, 25] . The dif fer ent BMPs induced sev eral early mark ers of BMP sig nal ing (smad-1/-5, runx2/cbfa-1 or os ter ix) and of bone min er al i za tion (bone sialo pro tein, oste o pon tin or ALP). Semi-quan ti ta tive RT-PCR anal y sis of mRNA expres sion was selected since it is well estab lished that upon bind ing of the BMPs to their cell recep tors, the expres sion of these genes is highly induced, trig gering oste o genic dif fer en ti a tion [1] . In C2C12 cells, BMP-4, -9 and -14 appeared to have had the most sig nifi cant effects in the mark ers of bone for ma tion. BMP-11 solely induced sig nifi cantly the BMP-activated tran scrip tion fac tor runx2, show ing that prob a bly this BMP does not have any impor tant role in bone for ma tion and heal ing, besides those described in the lit er a ture dur ing embry onic devel opment [14] . In human stem cells, BMP-4, -9 and -14 also dem on strated bio ac tiv ity, despite the fact that the oste o genic potential was higher for BMP-4 than BMP-9 or -14, which could point for the stron ger bone-induc ing potential of this cyto kine.
Despite the fact that these recombinant BMPs show bio ac tiv ity, fur ther stud ies will be per formed to assess the detailed response of cells to BMPs, includ ing the induc tion of the dif fer ent mark ers by RT-PCR, and immu no stain ing anal y sis.
In con clu sion, the approach we detailed herein shows a prom is ing route for pro duc ing large amounts of sev eral dif fer ent bio ac tive recombinant BMPs. The results in human adult stem cell cul tures sug gest that some of these BMPs could be used with success for future clin i cal appli ca tions.
